학술논문

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Document Type
Article
Source
In: Annals of the Rheumatic Diseases. (Annals of the Rheumatic Diseases, May 2011, 70(5):747-754)
Subject
Language
English
ISSN
00034967
14682060